$6.06
4.57%
Nasdaq, Oct 03, 10:03 pm CET

Neogen Corporation Stock price

$6.06
+0.34 5.94% 1M
-2.07 25.46% 6M
-6.08 50.08% YTD
-8.88 59.44% 1Y
-7.86 56.47% 3Y
-28.73 82.58% 5Y
-11.06 64.59% 10Y
+4.03 198.85% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
+0.27 4.57%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$2.1b
Net debt
$765.1m
Cash
$129.0m
Shares outstanding
216.6m
Valuation (TTM | estimate)
P/E
negative | 24.3
P/S
1.5 | 1.6
EV/Sales
2.3 | 2.5
EV/FCF
negative
P/B
0.6
Financial Health
Equity Ratio
60.1%
Return on Equity
-52.7%
ROCE
-0.1%
ROIC
-0.1%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$894.7m | $837.0m
EBITDA
$124.0m | $167.3m
EBIT
$-1.7m | $38.0m
Net Income
$-1.1b | $54.1m
Free Cash Flow
$-46.4m
Growth (TTM | estimate)
Revenue
-3.2% | -6.5%
EBITDA
-29.3% | 34.9%
EBIT
-102.9% | 2,359.7%
Net Income
-11,492.8% | 105.0%
Free Cash Flow
39.1%
Margin (TTM | estimate)
Gross
47.1%
EBITDA
13.9% | 20.0%
EBIT
-0.2%
Net
-122.1% | 6.5%
Free Cash Flow
-5.2%
More
EPS
$-5.0
FCF per Share
$-0.2
Short interest
13.2%
Employees
3k
Rev per Employee
$310.0k
Show more

Is Neogen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Neogen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Neogen Corporation forecast:

6x Buy
55%
5x Hold
45%

Analyst Opinions

11 Analysts have issued a Neogen Corporation forecast:

Buy
55%
Hold
45%

Financial data from Neogen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '25
+/-
%
895 895
3% 3%
100%
- Direct Costs 473 473
3% 3%
53%
421 421
9% 9%
47%
- Selling and Administrative Expenses 331 331
13% 13%
37%
- Research and Development Expense 21 21
6% 6%
2%
124 124
29% 29%
14%
- Depreciation and Amortization 126 126
8% 8%
14%
EBIT (Operating Income) EBIT -1.68 -1.68
103% 103%
0%
Net Profit -1,092 -1,092
11,493% 11,493%
-122%

In millions USD.

Don't miss a Thing! We will send you all news about Neogen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neogen Corporation Stock News

Neutral
Business Wire
10 days ago
LEXINGTON, Ky.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that it has renewed its commitment to the United States Equestrian Federation, extending the relationship first launched last year. Since joining US Equestrian in April 2024, Neogen has provided valuable support, resources, and educational tools to benefit the Federation and its members. As part of the renewed c...
Neutral
Business Wire
17 days ago
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on October 9, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North Ameri...
Neutral
Business Wire
20 days ago
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that David Naemura, Chief Financial Officer and Chief Operating Officer, has communicated his intention to depart the Company. Mr. Naemura will continue to serve in his existing roles until his departure, which is expected to occur after the Company's filing of its...
More Neogen Corporation News

Company Profile

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety, Animal Safety, and Corporate and Eliminations. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The Corporate and eliminations segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Head office United States
CEO John Adent
Employees 2,917
Founded 1981
Website www.neogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today